Zimmer Biomet Holdings Shares Outstanding 2006-2018 | ZBH

Zimmer Biomet Holdings shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Zimmer Biomet Holdings shares outstanding for the quarter ending September 30, 2018 were 0.205B, a 0.69% increase year-over-year.
  • Zimmer Biomet Holdings 2017 shares outstanding were 0.204B, a 0.64% increase from 2016.
  • Zimmer Biomet Holdings 2016 shares outstanding were 0.202B, a 6.64% increase from 2015.
  • Zimmer Biomet Holdings 2015 shares outstanding were 0.19B, a 10.54% increase from 2014.
Zimmer Biomet Holdings Annual Shares Outstanding
(Millions of Shares)
2017 204
2016 202
2015 190
2014 172
2013 172
2012 176
2011 189
2010 201
2009 216
2008 228
2007 238
2006 245
2005 250
Zimmer Biomet Holdings Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 205
Q2 2018 205
Q1 2018 205
Q4 2017 204
Q3 2017 204
Q2 2017 204
Q1 2017 203
Q4 2016 202
Q3 2016 203
Q2 2016 199
Q1 2016 202
Q4 2015 190
Q3 2015 206
Q2 2015 173
Q1 2015 173
Q4 2014 172
Q3 2014 172
Q2 2014 171
Q1 2014 172
Q4 2013 172
Q3 2013 172
Q2 2013 171
Q1 2013 171
Q4 2012 176
Q3 2012 175
Q2 2012 176
Q1 2012 179
Q4 2011 189
Q3 2011 189
Q2 2011 193
Q1 2011 194
Q4 2010 201
Q3 2010 200
Q2 2010 203
Q1 2010 204
Q4 2009 216
Q3 2009 215
Q2 2009 216
Q1 2009 222
Q4 2008 228
Q3 2008 226
Q2 2008 230
Q1 2008 234
Q4 2007 238
Q3 2007 237
Q2 2007 239
Q1 2007 239
Q4 2006 245
Q3 2006 243
Q2 2006 248
Q1 2006 250
Q4 2005 250
Q3 2005 250
Q2 2005 250
Q1 2005 249
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.421B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.569B 18.92
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Boston Scientific (BSX) United States $49.097B 24.81
Baxter (BAX) United States $34.600B 22.34
Smith & Nephew SNATS (SNN) United Kingdom $16.589B 0.00
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00